Literature DB >> 19202053

Acute inflammatory proteins constitute the organic matrix of prostatic corpora amylacea and calculi in men with prostate cancer.

Karen S Sfanos1, Brice A Wilson, Angelo M De Marzo, William B Isaacs.   

Abstract

Corpora amylacea (CA) are a frequent microscopic finding in radical prostatectomy specimens from men undergoing treatment for prostate cancer. Although often observed histologically to be associated with inflammation, the contribution of CA to prostatitis-related symptoms of unknown etiology or to prostate carcinogenesis remains unclear. Prostatic calculi (PC), which potentially represent calcified forms of CA, are less common but can cause urological disease including urinary retention and prostatitis. We conducted a comprehensive compositional analysis of CA/PC to gain insight into their biogenesis. Infrared spectroscopy analysis of calculi collected from 23 patients confirmed a prevalence of calcium phosphate in the form of hydroxyapatite. This result sets PC apart from most urinary stones, which largely are composed of calcium oxalate. Tandem mass spectrometry-based proteomic analysis of CA/PC revealed that lactoferrin is the predominant protein component, a result that was confirmed by Western blot analysis. Other proteins identified, including calprotectin, myeloperoxidase, and alpha-defensins, are proteins contained in neutrophil granules. Immunohistochemistry (IHC) suggested the source of lactoferrin to be prostate-infiltrating neutrophils as well as inflamed prostate epithelium; however, IHC for calprotectin suggested prostate-infiltrating neutrophils as a major source of the protein, because it was absent from other prostate compartments. This study represents a definitive analysis of the protein composition of prostatic CA and calculi and suggests that acute inflammation has a role in their biogenesis--an intriguing finding, given the prevalence of CA in prostatectomy specimens and the hypothesized role for inflammation in prostate carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19202053      PMCID: PMC2651291          DOI: 10.1073/pnas.0810473106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  S100 proteins in Corpora amylacea from normal human brain.

Authors:  D Hoyaux; C Decaestecker; C W Heizmann; T Vogl; B W Schäfer; I Salmon; R Kiss; R Pochet
Journal:  Brain Res       Date:  2000-06-09       Impact factor: 3.252

2.  In vitro characterization of lactoferrin aggregation and amyloid formation.

Authors:  Melanie R Nilsson; Christopher M Dobson
Journal:  Biochemistry       Date:  2003-01-21       Impact factor: 3.162

Review 3.  Prostate cancer.

Authors:  William G Nelson; Angelo M De Marzo; William B Isaacs
Journal:  N Engl J Med       Date:  2003-07-24       Impact factor: 91.245

4.  True prostatic calculus.

Authors:  A GENTILE
Journal:  J Urol       Date:  1947-04       Impact factor: 7.450

5.  Pancreatic stone protein of pancreatic calculi in chronic calcified pancreatitis in man.

Authors:  Chun Xiang Jin; Satoru Naruse; Motoji Kitagawa; Hiroshi Ishiguro; Takaharu Kondo; Shinobu Hayakawa; Tetsuo Hayakawa
Journal:  JOP       Date:  2002-03

6.  The x-ray diffraction pattern of prostatic corpora amylacea.

Authors:  B Gueft
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1972

7.  The keratin structure of corpora amylacea.

Authors:  G R Schrodt; M Murray
Journal:  Arch Pathol       Date:  1966-12

8.  Sexual factors and prostate cancer.

Authors:  G G Giles; G Severi; D R English; M R E McCredie; R Borland; P Boyle; J L Hopper
Journal:  BJU Int       Date:  2003-08       Impact factor: 5.588

9.  Ejaculation frequency and subsequent risk of prostate cancer.

Authors:  Michael F Leitzmann; Elizabeth A Platz; Meir J Stampfer; Walter C Willett; Edward Giovannucci
Journal:  JAMA       Date:  2004-04-07       Impact factor: 56.272

10.  Clinical correlation of prostatic lithiasis with chronic pelvic pain syndromes in young adults.

Authors:  Ioannis Geramoutsos; Kostis Gyftopoulos; Petros Perimenis; Vasiliki Thanou; Dimitra Liagka; Dimitrios Siamblis; George Barbalias
Journal:  Eur Urol       Date:  2004-03       Impact factor: 20.096

View more
  48 in total

Review 1.  The inflammatory microenvironment and microbiome in prostate cancer development.

Authors:  Karen S Sfanos; Srinivasan Yegnasubramanian; William G Nelson; Angelo M De Marzo
Journal:  Nat Rev Urol       Date:  2017-10-31       Impact factor: 14.432

2.  Bacterial Prostatitis Enhances 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine (PhIP)-Induced Cancer at Multiple Sites.

Authors:  Karen S Sfanos; Kirstie Canene-Adams; Heidi Hempel; Shu-Han Yu; Brian W Simons; Anthony J Schaeffer; Edward M Schaeffer; William G Nelson; Angelo M De Marzo
Journal:  Cancer Prev Res (Phila)       Date:  2015-05-19

3.  A Paracrine Role for IL6 in Prostate Cancer Patients: Lack of Production by Primary or Metastatic Tumor Cells.

Authors:  Shu-Han Yu; Qizhi Zheng; David Esopi; Anne Macgregor-Das; Jun Luo; Emmanuel S Antonarakis; Charles G Drake; Robert Vessella; Colm Morrissey; Angelo M De Marzo; Karen S Sfanos
Journal:  Cancer Immunol Res       Date:  2015-06-05       Impact factor: 11.151

4.  Elevated body mass index correlates with higher seminal plasma interleukin 8 levels and ultrasonographic abnormalities of the prostate in men attending an andrology clinic for infertility.

Authors:  F Lotti; G Corona; G M Colpi; E Filimberti; S Degli Innocenti; M Mancini; E Baldi; I Noci; G Forti; L Adorini; M Maggi
Journal:  J Endocrinol Invest       Date:  2011-07-07       Impact factor: 4.256

Review 5.  The diet as a cause of human prostate cancer.

Authors:  William G Nelson; Angelo M Demarzo; Srinivasan Yegnasubramanian
Journal:  Cancer Treat Res       Date:  2014

Review 6.  Prostate cancer and inflammation: the evidence.

Authors:  Karen S Sfanos; Angelo M De Marzo
Journal:  Histopathology       Date:  2012-01       Impact factor: 5.087

7.  Infiltrating Myeloid Cells Exert Protumorigenic Actions via Neutrophil Elastase.

Authors:  Irina Lerman; Maria de la Luz Garcia-Hernandez; Javier Rangel-Moreno; Luis Chiriboga; Chunliu Pan; Kent L Nastiuk; John J Krolewski; Aritro Sen; Stephen R Hammes
Journal:  Mol Cancer Res       Date:  2017-05-16       Impact factor: 5.852

8.  Are prostatic calculi independent predictive factors of lower urinary tract symptoms?

Authors:  Sung-Woo Park; Jong-Kil Nam; Sang-Don Lee; Moon-Kee Chung
Journal:  Asian J Androl       Date:  2009-12-07       Impact factor: 3.285

9.  Serum phospholipid fatty acids, genetic variation in myeloperoxidase, and prostate cancer risk in heavy smokers: a gene-nutrient interaction in the carotene and retinol efficacy trial.

Authors:  Ting-Yuan David Cheng; Irena B King; Matt J Barnett; Christine B Ambrosone; Mark D Thornquist; Gary E Goodman; Marian L Neuhouser
Journal:  Am J Epidemiol       Date:  2013-03-27       Impact factor: 4.897

Review 10.  Anti-inflammatory drugs, antioxidants, and prostate cancer prevention.

Authors:  Aditya Bardia; Elizabeth A Platz; Srinivasan Yegnasubramanian; Angelo M De Marzo; William G Nelson
Journal:  Curr Opin Pharmacol       Date:  2009-07-01       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.